ea0081p306 | Calcium and Bone | ECE2022
Dito Giorgia
, Degradi Chiara
, Guabello Gregorio
, Longhi Matteo
, Corbetta Sabrina
Osteoporosis is a chronic condition requiring long-term treatment; sequential treatment regimens with different agents represents an option aimed to increase bone mineral density (BMD) and then to maintain it. The loss of BMD occurring after withdrawal of teriparatide (TPT) can be prevented by bisphosphonates (BPs). Among BPs, data about the efficacy of zoledronic acid (ZOL) after TPT treatment are scanty. Here, we contribute to this topic providing data derived from the real-...